Cargando…
Statin Use in Patients With Chronic Liver Disease and Cirrhosis: Current Evidence and Future Directions
Chronic liver disease (CLD) and its complications constitute a significant cause of mortality and morbidity worldwide. Most deaths are secondary to the decompensation of cirrhosis and evolution of portal hypertension (PHTN). Since disease progression reversal is hardly attainable after decompensated...
Autores principales: | Kreidieh, Malek, Hamadi, Rachelle, Alsheikh, Mira, Al Moussawi, Hassan, Deeb, Liliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913022/ https://www.ncbi.nlm.nih.gov/pubmed/35369681 http://dx.doi.org/10.14740/gr1498 |
Ejemplares similares
-
The Incidence of Venous Thromboembolism and Practice of Deep Venous Thrombosis Prophylaxis Among Hospitalized Cirrhotic Patients
por: Alsheikh, Mira, et al.
Publicado: (2022) -
Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
por: Elhosseiny, Sherif, et al.
Publicado: (2019) -
Predictors of Deep Venous Thrombosis in Hospitalized Patients With Liver Cirrhosis in the US
por: Abou Yassine, Ahmad, et al.
Publicado: (2022) -
Beyond Pain Relief: Is Opioids Use Safe in Clostridium difficile Infection?
por: Al Moussawi, Hassan, et al.
Publicado: (2021) -
Granulocyte-colony stimulating factor in decompensated liver cirrhosis: a meta-analysis of four randomized controlled trials
por: Dimachkie, Reem, et al.
Publicado: (2023)